Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2026 13:04 ET | Source: Eascra Biotech

Eascra Biotech Welcomes Dr. Anne Yau as Life Science Research Scientist

Nanomedicine expert joins Massachusetts Biomedical Initiatives (MBI) lab in Worcester to advance RNA therapeutics for musculoskeletal disease
April 28, 2026 07:25 ET | Source: FormBlends

FormBlends Publishes 2026 State of Peptides Report as RFK-Era HHS Signals Major Shifts for GLP-1 and Peptide Therapy Access in the United States

MIAMI, FL, April 28, 2026 (GLOBE NEWSWIRE) -- FormBlends, a telehealth platform focused on medically supervised GLP-1 therapy and peptide research, today released its 2026 State of Peptides and...
April 27, 2026 16:30 ET | Source: Custom Market Insights

Global Compression Garments and Stockings Market Size/Share Worth USD 5.10 Billion by 2035 at a 4.8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Austin, TX, USA, April 28, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Compression Garments and Stockings Market Size, Trends and Insights By Product...
April 24, 2026 16:00 ET | Source: Compass Therapeutics

Compass Therapeutics to Announce Topline Secondary Endpoints from the Phase 2/3 COMPANION-002 Study of Tovecimig in Patients with Biliary Tract Cancer

Webcast scheduled for Monday, April 27, 2026 at 8:00am ET. BOSTON, April 24, 2026 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical...
April 23, 2026 07:00 ET | Source: Nasdaq, Inc.

Nasdaq Reports First Quarter 2026 Results; Strong Execution Drives Double-Digit Net Revenue Growth Across All Divisions

NEW YORK, April 23, 2026 (GLOBE NEWSWIRE) -- Nasdaq, Inc. (Nasdaq: NDAQ) today reported financial results for the first quarter of 2026. First quarter 2026 net revenue1 was $1.4 billion, an...
April 22, 2026 08:00 ET | Source: PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals Announces Board Chair Transition

PRINCETON, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of...
April 20, 2026 16:05 ET | Source: Kailera Therapeutics, Inc.

Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Kailera Therapeutics, Inc. (Nasdaq: KLRA), an advanced clinical-stage biotechnology company, today announced the closing of its initial public offering.
April 16, 2026 19:25 ET | Source: Kailera Therapeutics, Inc.

Kailera Therapeutics Announces Pricing of Initial Public Offering

Kailera Therapeutics, Inc. (Nasdaq: KLRA) today announced the pricing of its initial public offering.
April 15, 2026 07:00 ET | Source: Beeline Medicines Corporation

Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases

– Advancing a broad portfolio designed to deliver multiple paradigm-shifting therapies for devastating and underserved immune-mediated diseases – – Lead program afimetoran, a potential...
March 25, 2026 11:11 ET | Source: Faruqi & Faruqi LLP

NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or...